Recurrent Stroke in a Child With Atlantoaxial Instability Following Chiropractic Manipulation

2019 ◽  
Vol 42 (6) ◽  
pp. e518-e520 ◽  
Author(s):  
Majd T. Ghanim ◽  
Shayla Bergmann ◽  
Raymond D. Turner ◽  
Ramin Eskandari ◽  
Arash Mahajerin
Praxis ◽  
2003 ◽  
Vol 92 (5) ◽  
pp. 168-178
Author(s):  
Baumgartner ◽  
Georgiadis

Ce travail de revue présente la prévention secondaire des accidents vasculaire cérébraux par le traitement des facteurs de risque vasculaire, les inhibiteurs de l'agrégation plaquettaire, l'anticoagulation ou les thérapies endovasculaires. Deux études publiées récemment (PROtection aGainst Recurrent Stroke Study (PROGRESS) et la Heart Protection Study (HPS) ont pour la première fois pu démontrer l'efficacité d'un traitement contre l'hypertension et par statines dans la prévention secondaire après un accident vasculaire cérébral. PROGRESS a montré que la combinaison de perindopril et d'indapamide permet de réduire de 43% la survenue d'accidents vasculaires cérébraux ischémiques et hémorragiques chez les patients hypertendus ou normotendus alors que HPS a mis en évidence une diminution de 20% des accidents vasculaires cérébraux ischémiques chez les patients avec des taux sériques normaux ou élevés de cholestérol. Les sténoses carotidiennes symptomatiques avec un resserrement distal > ou égal à 70% sont opérées par endartérectomie; en cas de sténose distale de 50–69% une décision individuelle est prise; une endartérectomie n'est pas indiquée en cas de sténose < 50%. Les patients chez lesquels une source cardiaque d'embolie est mise en évidence doivent être anticoagulés (INR 2.5, intervalle: 2–3) à l'exception des myxomes cardiaques et des endocardites bactériennes. Si aucune intervention chirurgicale sur une artère cérébrale n'est indiquée ou si le patient ne doit pas être anticoagulé, on traite par un inhibiteur de l'agrégation plaquettaire: 100 mg d'aspirine ou la combinaison d'aspirine et de dipyridamol sont le traitement de choix. En cas de récidive d'ischémie sous aspirine ou d'intolérance à l'aspirine, le clopidogrel est prescrit. Comme alternative au clopidogrel en cas de récidive d'ischémie, une anticoagulation (INR 2.0, intervalle: 1.5–2.5) peut être prescrite.


2020 ◽  
Vol 91 (4) ◽  
pp. 352-357
Author(s):  
Jessica Tedford ◽  
Valerie Skaggs ◽  
Ann Norris ◽  
Farhad Sahiar ◽  
Charles Mathers

INTRODUCTION: Atrial fibrillation (AF) is one of the most common cardiac arrhythmias in the general population and is considered disqualifying aeromedically. This study is a unique examination of significant outcomes in aviators with previous history of both AF and stroke.METHODS: Pilots examined by the FAA between 2002 and 2012 who had had AF at some point during his or her medical history were reviewed, and those with an initial stroke or transient ischemic attack (TIA) during that time period were included in this study. All records were individually reviewed to determine stroke and AF history, medical certification history, and recurrent events. Variables collected included medical and behavior history, stroke type, gender, BMI, medication use, and any cardiovascular or neurological outcomes of interest. Major recurrent events included stroke, TIA, cerebrovascular accident, death, or other major events. These factors were used to calculate CHA2DS2-VASc scores.RESULTS: Of the 141 pilots selected for the study, 17.7% experienced a recurrent event. At 6 mo, the recurrent event rate was 5.0%; at 1 yr, 5.8%; at 3 yr 6.9%; and at 5 yr the recurrent event rate was 17.3%. No statistical difference between CHA2DS2-VASc scores was found as it pertained to number of recurrent events.DISCUSSION: We found no significant factors predicting risk of recurrent event and lower recurrence rates in pilots than the general population. This suggests CHA2DS2-VASc scores are not appropriate risk stratification tools in an aviation population and more research is necessary to determine risk of recurrent events in aviators with atrial fibrillation.Tedford J, Skaggs V, Norris A, Sahiar F, Mathers C. Recurrent stroke risk in pilots with atrial fibrillation. Aerosp Med Hum Perform. 2020; 91(4):352–357.


2016 ◽  
Vol 18 (9) ◽  
pp. 8-11 ◽  
Author(s):  
L.V. Stakhovskaya ◽  
◽  
O.A. Klochikhina ◽  
M.D. Bogatyreva ◽  
S.A. Chugunova ◽  
...  

2019 ◽  
Vol 30 (4) ◽  
pp. 541-544
Author(s):  
Justin Slavin ◽  
Marcello DiStasio ◽  
Paul F. Dellaripa ◽  
Michael Groff

The authors present a case report of a patient discovered to have a rotatory subluxation of the C1–2 joint and a large retroodontoid pannus with an enhancing lesion in the odontoid process eventually proving to be caused by gout. This patient represented a diagnostic conundrum as she had known prior diagnoses of not only gout but also sarcoidosis and possible rheumatoid arthritis, and was in the demographic range where concern for an oncological process cannot fully be ruled out. Because she presented with signs and symptoms of atlantoaxial instability, she required posterior stabilization to reduce the rotatory subluxation and to stabilize the C1–2 instability. However, despite the presence of a large retroodontoid pannus, she had no evidence of spinal cord compression on physical examination or imaging and did not require an anterior procedure to decompress the pannus. To confirm the diagnosis but avoid additional procedures and morbidity, the authors proceeded with the fusion as well as a posterior biopsy to the retroodontoid pannus and confirmed a diagnosis of gout.


Sign in / Sign up

Export Citation Format

Share Document